Literature DB >> 22415465

Combination radiotherapy in an orthotopic mouse brain tumor model.

Tamalee R Kramp1, Kevin Camphausen.   

Abstract

Glioblastoma multiforme (GBM) are the most common and aggressive adult primary brain tumors. In recent years there has been substantial progress in the understanding of the mechanics of tumor invasion, and direct intracerebral inoculation of tumor provides the opportunity of observing the invasive process in a physiologically appropriate environment. As far as human brain tumors are concerned, the orthotopic models currently available are established either by stereotaxic injection of cell suspensions or implantation of a solid piece of tumor through a complicated craniotomy procedure. In our technique we harvest cells from tissue culture to create a cell suspension used to implant directly into the brain. The duration of the surgery is approximately 30 minutes, and as the mouse needs to be in a constant surgical plane, an injectable anesthetic is used. The mouse is placed in a stereotaxic jig made by Stoetling (figure 1). After the surgical area is cleaned and prepared, an incision is made; and the bregma is located to determine the location of the craniotomy. The location of the craniotomy is 2 mm to the right and 1 mm rostral to the bregma. The depth is 3 mm from the surface of the skull, and cells are injected at a rate of 2 μl every 2 minutes. The skin is sutured with 5-0 PDS, and the mouse is allowed to wake up on a heating pad. From our experience, depending on the cell line, treatment can take place from 7-10 days after surgery. Drug delivery is dependent on the drug composition. For radiation treatment the mice are anesthetized, and put into a custom made jig. Lead covers the mouse's body and exposes only the brain of the mouse. The study of tumorigenesis and the evaluation of new therapies for GBM require accurate and reproducible brain tumor animal models. Thus we use this orthotopic brain model to study the interaction of the microenvironment of the brain and the tumor, to test the effectiveness of different therapeutic agents with and without radiation.

Entities:  

Mesh:

Year:  2012        PMID: 22415465      PMCID: PMC3460572          DOI: 10.3791/3397

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

1.  Trapping the mouse genome to hunt human alterations.

Authors:  Anne-Marie Bleau; Eric C Holland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-03       Impact factor: 11.205

2.  Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity.

Authors:  Chris A Learn; Peter M Grossi; Robert J Schmittling; Weihua Xie; Duane A Mitchell; Isaac Karikari; ZhengZheng Wei; Holly Dressman; John H Sampson
Journal:  J Neuroimmunol       Date:  2006-11-29       Impact factor: 3.478

3.  An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.

Authors:  Yunge Zhao; Aizhen Xiao; Charles G diPierro; Joan E Carpenter; Rana Abdel-Fattah; Gerard T Redpath; Maria-Beatriz S Lopes; Isa M Hussaini
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

4.  Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.

Authors:  Marianela Candolfi; James F Curtin; W Stephen Nichols; Akm G Muhammad; Gwendalyn D King; G Elizabeth Pluhar; Elizabeth A McNiel; John R Ohlfest; Andrew B Freese; Peter F Moore; Jonathan Lerner; Pedro R Lowenstein; Maria G Castro
Journal:  J Neurooncol       Date:  2007-09-15       Impact factor: 4.130

5.  Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2.

Authors:  Tobias Martens; Yvonne Laabs; Hauke S Günther; Dirk Kemming; Zhenping Zhu; Larry Witte; Christian Hagel; Manfred Westphal; Katrin Lamszus
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

6.  Development of a xenograft glioma model in mouse brain.

Authors:  A H Kaye; G Morstyn; I Gardner; K Pyke
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

7.  A murine model of intracranial invasion: morphological observations on central nervous system invasion by murine melanoma cells.

Authors:  B J McGrady; D McCormick
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

8.  Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.

Authors:  Mitsugu Fujita; Xinmei Zhu; Kotaro Sasaki; Ryo Ueda; Keri L Low; Ian F Pollack; Hideho Okada
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

Review 9.  Advances in the genetics of glioblastoma: are we reaching critical mass?

Authors:  Benjamin Purow; David Schiff
Journal:  Nat Rev Neurol       Date:  2009-07-14       Impact factor: 44.711

10.  Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar.

Authors:  Xi Feng Fei; Quan Bin Zhang; Jun Dong; Yi Diao; Zhi Min Wang; Ru Jun Li; Zi Cheng Wu; Ai Dong Wang; Qing Lan; Shi Ming Zhang; Qiang Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-06-29
  10 in total
  7 in total

1.  Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.

Authors:  Pilar de la Puente; Nicole Fettig; Micah J Luderer; Abbey Jin; Shruti Shah; Barbara Muz; Vaishali Kapoor; Sreekrishna M Goddu; Noha Nabil Salama; Christina Tsien; Dinesh Thotala; Kooresh Shoghi; Buck Rogers; Abdel Kareem Azab
Journal:  J Pharm Sci       Date:  2017-11-21       Impact factor: 3.534

2.  Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.

Authors:  Cheng-Chia Wu; Kunal R Chaudhary; Yong Hum Na; David Welch; Paul J Black; Adam M Sonabend; Peter Canoll; Yvonne M Saenger; Tony J C Wang; Cheng-Shie Wuu; Tom K Hei; Simon K Cheng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-19       Impact factor: 7.038

3.  [Interference of P2X4 receptor expression in tumor-associated macrophages suppresses migration and invasion of glioma cells].

Authors:  X Yang; H Shen; Q Li; Z Dai; R Yang; G Huang; R Chen; F Wang; J Song; H Hua
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

Review 4.  Preclinical models in radiation oncology.

Authors:  Jenna Kahn; Philip J Tofilon; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2012-12-27       Impact factor: 3.481

5.  Ly6G+ inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model.

Authors:  Hee-Young Jeon; Seok Won Ham; Jun-Kyum Kim; Xiong Jin; Seon Yong Lee; Yong Jae Shin; Chang-Yong Choi; Jason K Sa; Se Hoon Kim; Taehoon Chun; Xun Jin; Do-Hyun Nam; Hyunggee Kim
Journal:  Cell Death Differ       Date:  2019-02-25       Impact factor: 15.828

6.  Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging.

Authors:  Jennifer A Geisler; Jonathan M Spehar; Sarah A Steck; Anna Bratasz; Reena Shakya; Kimerly Powell; Gina M Sizemore
Journal:  J Vis Exp       Date:  2020-06-07       Impact factor: 1.355

7.  Verification of 5-Aminolevurinic Radiodynamic Therapy Using a Murine Melanoma Brain Metastasis Model.

Authors:  Junko Takahashi; Shinsuke Nagasawa; Mitsushi J Ikemoto; Chikara Sato; Mari Sato; Hitoshi Iwahashi
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.